SCHEMBL20034713

SCHEMBL20034713

CN(C)C1CCN(C(=O)CCCC(=O)ON2C(=O)CCC2=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.43
▸ L3MBTL3 Q96JM7 2/20 0.40
▸ CDYL Q9Y232 1/20 0.38
▸ CDY1; CDY1B Q9Y6F8 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ MGLL Q99685 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ EPHX1 P07099 2/20 0.35
▸ EPHX2 P34913 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ GNAI3 P08754 1/20 0.35
▸ GNAO1 P09471 1/20 0.35
▸ GNAI1 P63096 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19703694 0.86 NPC1 (0.62) NPC1GLAL3MBTL1RAB9AEPHX1
SCHEMBL17740037 0.83 NPC1 (0.43) NPC1GLAL3MBTL1RAB9AEPHX1
SCHEMBL19698112 0.82 NPC1 (0.43) NPC1GLAL3MBTL1RAB9AEPHX1
SCHEMBL18824020 0.80 GLA (0.46) NPC1GLAL3MBTL1RAB9AATM
SCHEMBL19703782 0.78 NPC1 (0.53) NPC1RAB9AMEN1ALDH1A1LMNA
SCHEMBL19860906 0.77 KMT2A (0.50) NPC1L3MBTL1RAB9AATMMEN1
SCHEMBL22777675 0.76 SMN1; SMN2 (0.36) GLAMGLLLMNAHPGDKMT2A
SCHEMBL34383 0.76 SMN1; SMN2 (0.36) GLAMGLLLMNAHPGDKMT2A
SCHEMBL19698575 0.75 NPC1 (0.39) NPC1GLAL3MBTL1RAB9AEPHX1
SCHEMBL14586579 0.75 DNM1 (0.36) MGLLL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938323-B2 Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase NOVARTIS AG (CH) 2018-04-10 — — US disclosed
Send feedback